Esma Lejmi

Title: Esma Lejmi: Innovator in Protein Research

Introduction

Esma Lejmi is a notable inventor based in Issy les Moulineaux, France. She has made significant contributions to the field of protein research, particularly in the development of therapeutic proteins. Her work has implications for drug development and medical research.

Latest Patents

Esma Lejmi holds a patent for "Mutated netrin 4, fragments thereof and uses thereof as drugs." This patent includes proteins that have the amino acid sequence of SEQ ID NO: 2 or SEQ ID NO: 4, along with fragments of these sequences. The protein fragments are represented by the sequences of SEQ ID NO: 2q, where q varies from 3 to 36, and the sequences of SEQ ID NO: 185 to SEQ ID NO: 209. Additionally, nucleotide sequences coding for these proteins are also provided in her patent.

Career Highlights

Throughout her career, Esma has worked with prestigious institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. Her research has focused on innovative approaches to protein functionality and therapeutic applications.

Collaborations

Esma has collaborated with esteemed colleagues, including Jean Plouët and Laurence Leconte. These partnerships have enhanced her research and contributed to advancements in the field.

Conclusion

Esma Lejmi is a pioneering inventor whose work in protein research has the potential to impact drug development significantly. Her contributions to the scientific community are noteworthy and continue to inspire future innovations.